Recursion Pharmaceuticals (RXRX) is back in focus after management detailed AI driven gains in drug discovery, including 25 new targets identified at once, as investors look ahead to an earnings ...
As AI tools like OpenAI’s GPT-5.5 and Anthropic’s Claude Design expand capabilities in coding and visual creation, experts warn of a homogenization of ideas and loss of creative distinction. Studies ...
While the confident stride through life with unexamined certainty, those who truly know themselves are caught in an endless ...
Opinion
2dOpinion
To be human is to live with friction. That’s something AI boosters will never understand
We’re being sold a world where there’s no room for reflection or spontaneity. This is the Black Mirror stage of capitalism, says Alexander Hurst, who writes for Guardian Europe from Paris ...
Stanford's James Zou targets $1B valuation for AI physiology startup backed by Nature-published research and FDA-cleared cardiac AI ...
As Project Hail Mary grips audiences with its mix of science and survival, these five gripping novels offer more journeys ...
In a first-of-its-kind finding, researchers at University of Iowa Health Care discovered that specific genetic sequences have ...
At the start of Ben Lerner's startling new novel "Transcription," a man sits on a train trying to read and failing because he ...
The big SpaceX IPO is coming, and it could probably become the new, more exciting way to bet on Elon Musk’s vision of the ...
AI is forcing a measurement crisis we’ve avoided for 100 years. If AI can write our emails, analyze data, and generate code, ...
The current problem with DeFi is that the organic demand for on-chain credit, borrowing to fund productive economic activity, ...
Magic just didn’t do that. When The Walking Dead showed up as a mechanically unique Secret Lair in 2020, it sparked more ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results